Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALBEMARLE CORPALB · Entity 2581 | General Counsel & Sec | February 27, 2025 | March 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALBEMARLE CORP
Report date February 27, 2025 · Filed March 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,542 |
Ending reported balance
After 2025-02-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-02-27 · Grant · Acquired 2,533 · Balance 4,476 F1: Restricted Stock Units ("RSUs") vest 100% on 02/27/2028, subject to the terms of the award agreement. Row 2 · 2025-02-27 · Grant · Acquired 5,066 · Balance 9,542 F2: RSUs vest 100% on 02/27/2027, subject to the terms of the award agreement. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $78.97 · Expires 2035-02-27 | Direct | 5,918 |
Reported balance
After 2025-02-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-02-27 · Grant · Acquired 5,918 · Balance 5,918 |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units ("RSUs") vest 100% on 02/27/2028, subject to the terms of the award agreement.
F2: RSUs vest 100% on 02/27/2027, subject to the terms of the award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2025 Filed Mar 3, 2025 23:25 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantStock Options · Derivative | 5,918 | $0.00 Strike: $78.97 | $0.00 |
DisclosureSEC source: 0000915913-25-000063 · wk-form4_1741044325.xml · derivative · entry 3 Grant Stacy Goto · CIK 0002040725 · General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,918 Underlying: Common Stock · 5,918 shares Expires 2035-02-27 Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 23:25 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 5,066 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000063 · wk-form4_1741044325.xml · nonDerivative · entry 2 Grant Stacy Goto · CIK 0002040725 · General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,542 F2 · shares: RSUs vest 100% on 02/27/2027, subject to the terms of the award agreement. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 23:25 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000063 · wk-form4_1741044325.xml · nonDerivative · entry 1 Grant Stacy Goto · CIK 0002040725 · General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,476 F1 · shares: Restricted Stock Units ("RSUs") vest 100% on 02/27/2028, subject to the terms of the award agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.